Fineline Cube

Follow:
14455 Articles
Company

HutchMed’s 2023 Financials Show 102% YOY Revenue Growth and Robust Collaboration with Takeda

CompanyDeals

Angitia Bio Secures USD 40 Million in Series B+ Financing to Advance Musculoskeletal Disorder Therapies

CompanyDeals

BMS Taps into Circular RNA Potential with Shanghai Circode Bio Agreement

CompanyDeals

AbbVie Partners with OSE Immunotherapeutics to Develop First-in-Class Immunotherapy OSE-230

CompanyDrug

AstraZeneca’s AZD0486 Receives NMPA Greenlight for Clinical Study in B-Cell Leukemia

Company

Viatris Eyes Growth After Concluding Initial Phase of Strategy with 2023 Sales at $15.4 Billion

CompanyDrug

BMS’s Azacitidine, First Oral AML Therapy, Reaches GBA Patients via Special Policy

CompanyDrug

Abbisko Therapeutics Reports Positive Phase I Results for ABSK061 in Solid Tumors at ESMO TAT 2024

CompanyDrug

Cutia Therapeutic’s CU-20401 Shows Promising Safety and Efficacy in Phase I Abdominal Fat Reduction Study

CompanyDrug

Shandong Buchang Pharmaceuticals Gets NMPA Greenlight for Phase I Study of BC001 in Solid Tumors

CompanyDrug

Bayer’s BAY 2927088 Receives FDA Breakthrough Therapy Designation for HER2-Mutated NSCLC

CompanyDrug

Haisco Pharmaceutical Gets NMPA Greenlight for HSK39775 Solid Tumor Drug Candidate